277 related articles for article (PubMed ID: 15764204)
1. Cure of multidrug-resistant Acinetobacter baumannii bacteraemia with continuous intravenous infusion of colistin.
Michalopoulos A; Kasiakou SK; Rosmarakis ES; Falagas ME
Scand J Infect Dis; 2005; 37(2):142-5. PubMed ID: 15764204
[TBL] [Abstract][Full Text] [Related]
2. Treatment of nosocomial meningitis due to a multidrug resistant Acinetobacter baumannii with intraventricular colistin.
Bukhary Z; Mahmood W; Al-Khani A; Al-Abdely HM
Saudi Med J; 2005 Apr; 26(4):656-8. PubMed ID: 15900379
[TBL] [Abstract][Full Text] [Related]
3. Preventing strategy of multidrug-resistant Acinetobacter baumanii susceptible only to colistin in cardiac surgical intensive care units.
Mastoraki A; Douka E; Kriaras I; Stravopodis G; Saroglou G; Geroulanos S
Eur J Cardiothorac Surg; 2008 Jun; 33(6):1086-90. PubMed ID: 18339553
[TBL] [Abstract][Full Text] [Related]
4. Successful treatment of meningitis caused by multidrug-resistant Acinetobacter baumannii with intravenous and intrathecal colistin.
Ho YH; Wang LS; Chao HJ; Chang KC; Su CF
J Microbiol Immunol Infect; 2007 Dec; 40(6):537-40. PubMed ID: 18087636
[TBL] [Abstract][Full Text] [Related]
5. Colistin and rifampicin in the treatment of nosocomial infections from multiresistant Acinetobacter baumannii.
Motaouakkil S; Charra B; Hachimi A; Nejmi H; Benslama A; Elmdaghri N; Belabbes H; Benbachir M
J Infect; 2006 Oct; 53(4):274-8. PubMed ID: 16442632
[TBL] [Abstract][Full Text] [Related]
6. Colistin offers prolonged survival in experimental infection by multidrug-resistant Acinetobacter baumannii: the significance of co-administration of rifampicin.
Pantopoulou A; Giamarellos-Bourboulis EJ; Raftogannis M; Tsaganos T; Dontas I; Koutoukas P; Baziaka F; Giamarellou H; Perrea D
Int J Antimicrob Agents; 2007 Jan; 29(1):51-5. PubMed ID: 17189095
[TBL] [Abstract][Full Text] [Related]
7. Colistin and rifampicin in the treatment of multidrug-resistant Acinetobacter baumannii infections.
Bassetti M; Repetto E; Righi E; Boni S; Diverio M; Molinari MP; Mussap M; Artioli S; Ansaldi F; Durando P; Orengo G; Bobbio Pallavicini F; Viscoli C
J Antimicrob Chemother; 2008 Feb; 61(2):417-20. PubMed ID: 18174197
[TBL] [Abstract][Full Text] [Related]
8. Amikacin and colistin for treatment of Acinetobacter baumannii meningitis.
Fulnecky EJ; Wright D; Scheld WM; Kanawati L; Shoham S
J Infect; 2005 Dec; 51(5):e249-51. PubMed ID: 15913780
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of multidrug-resistant Acinetobacter baumannii ventriculitis with intrathecal and intravenous colistin.
De Pascale G; Pompucci A; Maviglia R; Spanu T; Bello G; Mangiola A; Scoppettuolo G
Minerva Anestesiol; 2010 Nov; 76(11):957-60. PubMed ID: 20445494
[TBL] [Abstract][Full Text] [Related]
10. Colistin serum concentrations after intravenous administration in critically ill patients with serious multidrug-resistant, gram-negative bacilli infections: a prospective, open-label, uncontrolled study.
Markou N; Markantonis SL; Dimitrakis E; Panidis D; Boutzouka E; Karatzas S; Rafailidis P; Apostolakos H; Baltopoulos G
Clin Ther; 2008 Jan; 30(1):143-51. PubMed ID: 18343250
[TBL] [Abstract][Full Text] [Related]
11. Colistin efficacy in an experimental model of Acinetobacter baumannii endocarditis.
Rodríguez-Hernández MJ; Jiménez-Mejias ME; Pichardo C; Cuberos L; García-Curiel A; Pachón J
Clin Microbiol Infect; 2004 Jun; 10(6):581-4. PubMed ID: 15191391
[TBL] [Abstract][Full Text] [Related]
12. [Intrathecal use of colistin].
Charra B; Hachimi A; Benslama A; Motaouakkil S
Ann Fr Anesth Reanim; 2006 Feb; 25(2):215. PubMed ID: 16311006
[No Abstract] [Full Text] [Related]
13. Safety in treatment of ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumannii with aerosolized colistin in neonates: a preliminary report.
Nakwan N; Wannaro J; Thongmak T; Pornladnum P; Saksawad R; Nakwan N; Chokephaibulkit K
Pediatr Pulmonol; 2011 Jan; 46(1):60-6. PubMed ID: 20812247
[TBL] [Abstract][Full Text] [Related]
14. Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP.
Garnacho-Montero J; Ortiz-Leyba C; Jiménez-Jiménez FJ; Barrero-Almodóvar AE; García-Garmendia JL; Bernabeu-WittelI M; Gallego-Lara SL; Madrazo-Osuna J
Clin Infect Dis; 2003 May; 36(9):1111-8. PubMed ID: 12715304
[TBL] [Abstract][Full Text] [Related]
15. Colistin as a salvage therapy for nosocomial infections caused by multidrug-resistant bacteria in the ICU.
Kallel H; Bahloul M; Hergafi L; Akrout M; Ketata W; Chelly H; Hamida CB; Rekik N; Hammami A; Bouaziz M
Int J Antimicrob Agents; 2006 Oct; 28(4):366-9. PubMed ID: 16971093
[TBL] [Abstract][Full Text] [Related]
16. Treatment of multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii pneumonia.
Falagas ME; Kasiakou SK; Michalopoulos A
J Cyst Fibros; 2005 May; 4(2):149-50. PubMed ID: 15886070
[No Abstract] [Full Text] [Related]
17. Cure of multidrug-resistant Acinetobacter baumannii fixation device-related orthopedic infections in two patients with intravenous colistin.
Kasiakou SK; Fragoulis K; Tzagarakis G; Mistidis P; Kapaskelis A; Falagas ME
Microb Drug Resist; 2005; 11(3):287-9. PubMed ID: 16201933
[TBL] [Abstract][Full Text] [Related]
18. Intravenous and inhalational colistin-induced respiratory failure.
Wahby K; Chopra T; Chandrasekar P
Clin Infect Dis; 2010 Mar; 50(6):e38-40. PubMed ID: 20146630
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic options for Acinetobacter baumannii infections.
Vila J; Pachón J
Expert Opin Pharmacother; 2008 Mar; 9(4):587-99. PubMed ID: 18312160
[TBL] [Abstract][Full Text] [Related]
20. Successful treatment of multidrug-resistant Acinetobacter baumannii central nervous system infections with colistin.
Katragkou A; Roilides E
J Clin Microbiol; 2005 Sep; 43(9):4916-7. PubMed ID: 16145177
[No Abstract] [Full Text] [Related]
[Next] [New Search]